This week's research highlights that anxiety and depression are real, common struggles for people living with IPF — and that an AI-tested drug combination showed remarkable promise in preserving lung function.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
A new study confirmed something many of you already feel: living with IPF (a lung-scarring disease) takes a real toll on mental health. Researchers found that the worse someone's breathing difficulties are, the more likely they are to experience anxiety and depression. This is not weakness — it is a recognized part of the disease that deserves care and attention, just like the physical symptoms.
An AI tested seven different drug combinations to find which best protected lung function. The winner kept FVC (a measure of how much air your lungs can hold and push out) at an impressive 98.3% — meaning lungs stayed very close to healthy capacity. The combination included inhaled medicines and treatments targeting the scarring process at its root. This is still early-stage research, not yet available as treatment, but the direction is genuinely exciting.
One question to ask your lung doctor at your next visit: 'Are there any mental health support resources — like a counselor or support group — you can connect me with alongside my physical treatment?'